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ABSTRACT 
Myocardial tissue lacks the ability to regenerate itself significantly following a 
myocardial infarction. Thus, new strategies that could compensate this lack are of high 
interest. Cardiac tissue engineering (CTE) strategies are a relatively new approach that 
aims to compensate the tissue loss using combination of biomaterials, cells and 
bioactive molecules. The goal of the present study was to evaluate cell survival and 
growth, seeding capacity and cellular phenotype maintenance of subcutaneous adipose 
tissue derived progenitor cells (subATDPCs) in a new synthetic biomaterial scaffold 
platform. Specifically, here we tested the effect of the RAD16-I peptide gel in micro-
porous poly(ethyl acrylate) polymers (PEA) using two-dimensional PEA films as 
controls. Results showed optimal cell adhesion efficiency and growth in the polymers 
coated with the self-assembling peptide RAD16-I. Importantly, subATDPCs seeded into 
microporous PEA scaffolds coated with RAD16-I maintained its phenotype by 
assessing specific progenitor markers using protein and gene expression analysis. These 
data suggest that this bioimplant (scaffold/RAD16-I/cells) can be suitable for further in 
vivo implantation with the aim to improve the function of affected tissue after 
myocardial infarction. 
1. INTRODUCTION 
Tissue or organ damage loss through disease and trauma are one of the most common, 
harmful and costly problems in human health care. Nowadays, treatment options 
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include transplantation, medical devices, surgical reconstructions and in few cases drug 
therapy. However, these techniques present associated problems and none of them 
shows a satisfactory long-term recovery [1]. For this reason, Tissue Engineering (TE) 
emerged as a significant potential alternative or complementary solution that combines 
scaffolds, cells and/or bioactive molecules with the aim to develop biological substitutes 
that maintain, improve or restore tissue function [2].  
According to the World Health Organization, nowadays myocardial infarction (MI), 
which results from oxygen insufficiency producing ischemic necrotic tissue, leads to 29 
% of deaths worldwide [3,4]. After MI, heart muscle regeneration through biological 
mechanisms is not enough to compensate the large-scale tissue loss, and cellular 
therapies appear as a good alternative to the actual treatments. The first attempt of cell 
therapies was direct cell injection, but it was reported to obtain poor engraftment and 
viability [5,6]. In this scenario, Cardiac Tissue Engineering (CTE) opens a new 
approach to address the development of cardiac tissue patches with the aim to increase 
cell engraftment and viability with the hope to promote the neoformation of functional 
myocardial tissue. Right now, it is not possible to make a clear statement on CTE 
efficiency but different in vivo studies have shown encouraging results [7–9], which 
have led the scientific community to develop and improve new strategies.  
Different cell types are under research as potential sources for cardiac cell therapy, 
including cardiac myocytes, skeletal myoblasts as well as embryonic stem cells (ESCs) 
and adult stem cells (ASCs). Interesting reviews have been published during the last 
years referring to this field [7,8,10]. In the present study, ASCs have been employed. 
This kind of cells can be obtained from various tissues including bone marrow [11,12], 
adipose tissue [12–17], and umbilical cord [18,19]. Their principal advantage is their 
ease of isolation from the own patient, which decrease the risk of immune response or 
tumors generation. Specifically, subcutaneous adipose tissue derived progenitor cells 
(subATDPCs) from cardiac adipose tissue origin were used herein. As cells cannot 
withstand the mechanical and biophysical extreme conditions experienced in the 
ischemic heart, we propose to seed the cells in a scaffold in order to obtain a bioactive 
patch. The scaffold could serve as a carrier and early biomechanical support for 
implanted subATDPCs [4].  
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Nowadays, different materials in combination or not of different cell types are being 
tested to improve tissue function. The polymers employed so far, with the aim to obtain 
these scaffolds, include natural and synthetic polymers. Collagen, gelatin, fibrin, 
hyaluronic acid and alginate [20,21] from natural origin are widely used. Additionally, 
synthetic polymers such as poly(ethylene glycol) (PEG), polylactide acid (PLA), 
polylactide-co-glycolic acid (PLGA), polycaprolactone (PCL) and poly(glycerol 
sebacate) (PGS) [22,23] with different architectures are under study. Since the heart is 
an organ of unparalleled complexity with contractile, conductive and vascular systems, 
the ideal material for CTE should meet a series of requirements [24]. First of all, it 
should serve as biological, biophysical and mechanical support for cell growth, function 
and differentiation. The material should closely mimic the heart architecture and allow 
the remodeling of the extracellular matrix (ECM). Additionally, a proper interaction 
with the host tissues, promoting rapid vascularization and host macrophage infiltration 
in order to remove cellular debris is also important. Moreover, due to the continuous 
expansion and contraction of heart tissue, the material must be stress and strain 
resistant, but elastic enough to enable contractile forces transmission [4]. All these 
characteristics are difficult to be achieved with a sole material, and for this reason we 
propose that a combination of biomaterials could better satisfy the mentioned requisites. 
Thus, a combination of an elastomeric microporous membrane, poly(ethyl acrylate), 
PEA [25,26] filled with RAD16-I self-assembling peptide was proposed. PEA 
elastomeric membrane can satisfy the mechanic and structural requirements of the heart 
and provide biomechanical support to cells while RAD16-I was added to improve cell 
colonization and survival within the scaffold [27]. 
PEA is a synthetic hydrophobic material with excellent biological performance and 
mechanical properties (elastic and loss moduli) similar to those of soft organic tissues 
[28]. Interestingly, it has shown good compatibility in vitro and in vivo with different 
cell types: chondrocytes, osteoblasts, keratocytes, human umbilical vein endothelial 
cells, neural cells, or dental pulp stem cells [29–32]. Additionally, PEA has been shown 
to adsorb on its surface ECM adhesion molecules that are amiably recognized by cells 
[33,34]. On the other hand, RAD16-I (more than 99% water) is used to provide an 
appropriate microenvironment to the implanted cells. It has been previously reported to 
promote growth and proliferation of multiple cell types, including chondrocytes, 
 4 
hepatocytes, endothelial cells, neuronal cells [35–39], as well as mouse embryonic stem 
cells and mouse embryonic fibroblasts [40,41]. 
Therefore, the combination of PEA elastomeric membrane and RAD16-I gel can 
overcome the shortcomings of both materials. The final aim was to obtain a bioactive 
implant that can be used as a carrier for cell delivery and promote improvements in 
cardiac function. This could be achieved by providing structural and nutrient support for 
transplanted cells survival, better integration with the host tissue, and re-population of 
injured non-contractile ventricle. 
The methodology associated to the combination of these materials and cells was 
addressed in previous works [42]. In the present work we used these material platform 
to study the behavior of subATDPCs in terms of cell viability, growth, patch 
distribution and analysis of early and definitive cardiac markers. 
2. MATERIALS AND METHODS 
2.2  Preparation of the composites (PEA+RAD16-I) 
Preparation of poly(ethyl acrylate), PEA, scaffolds: Poly(ethyl acrylate) elastomeric 
scaffolds with interconnected spherical pores were obtained by an ultraviolet 
polymerization of the monomer mixture and a template leaching technique, following 
the procedure described in [43,44]. Briefly, ethyl acrylate (99 %, Sigma Aldrich) 
monomer was mixed with 1 wt % of benzoin (98 %, Scharlau) as photo-initiator and 2 
wt % of ethylene glycol dimethacrylate (98 %, Sigma Aldrich) as cross-linker, stirred 
for 20 min, injected in a porogen template consisting of sintered poly(methyl 
methacrylate) microspheres of 130 ± 20 μm in diameter (PMMA; Colacryl dp 300), 
polymerized in a mold, and postcured in an oven at 90 ºC for 24 h. After 
polymerization, the PMMA templates, as well as residual substances of low molecular 
weight, were removed by soxhlet extraction with acetone (Scharlab). Next, the solvent 
was slowly exchanged with water, and the scaffolds were dried under vacuum. Films 
were obtained by a polymerization of the monomer mixture in a plane glass mold, to be 
used as controls. The final thickness was 0.8 mm approximately.  
Samples were cut from both the scaffolds and the films as 5 and 8 mm-diameter circles 
for in vitro assays. Previous to in vitro assays, PEA elastomeric membranes were 
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sterilized with a 25 kGy dose of gamma irradiation in a 
60
Co source (Aragogamma, 
Barcelona, Spain). 
Loading of RAD16-I and characterization of the obtained composite: The self-
assembling peptide RAD16-I (PuraMatrix™ 1 % (w/v), BD Biosciences) was used as a 
filler hydrogel of PEA scaffolds pores [34]. Prior to its use, RAD16-I was sonicated in a 
Bandelin bath for 30 min at 25 ºC applying 30 W in order to decrease its viscosity. 
Then, it was diluted to 0.15 % (w/v) with water (extra pure, Scharlau) and vortexed 
(Elmi SkyLine) to ensure homogenization before its loading in the pores of the 
elastomeric membranes. Each membrane was submerged in a peptide 0.15 % solution 
and with the help of the vacuum it was forced to penetrate in the voids of the porous 
structure, displacing the air. The gelling of RAD16-I peptide inside the pores was 
induced by soaking with phosphate buffer saline (PBS) during 30 min and assessed in a 
Hitachi S4800 scanning electron microscopy (SEM) [34]. Bare PEA scaffolds were 
observed as controls (see Figure 1). 
2.3 Cell expansion and seeding in bare scaffolds and composites 
Cell expansion: Subcutaneous adipose tissue derived progenitor cells (subATDPCs)
*
 
were isolated from fat pads between skin and sternum from patients undergoing cardiac 
surgery and processed as previously described [45,46]. Informed consent was obtained 
from all subjects, and the study protocol conformed to the principles outlined in the 
Declaration of Helsinki. The extracted adherent cells were expanded in culture plates 
under standard conditions (37 °C and 5 % CO2) in α-MEM (Sigma) supplemented with 
10 % fetal bovine serum (Lonza) and 1 % penicillin-streptomycin (Labclinics), 1 % L-
glutamine (Labclinics) and 5 µg/mL plasmocin (Invivogen). At the third passage cells 
of five patients were mixed to obtain a pool. The subsequent experiments were 
performed at passage eight. 
Cell seeding in bare scaffolds and composites: RAD16-I 0.15 % solution was loaded in 
the pores of PEA scaffolds of the two sizes as explained. Next, samples of 8 mm 
diameter were placed in a 48-well plate and those of 5 mm diameter were placed in a 
96-well plate. In parallel, subATDPCs were trypsinized and divided into two aqueous 
solutions of final concentrations of 10000 cells/µL and 5000 cells/µL with 10 % 
                                                     
*
 Kindly provided by Dr. Carolina Soler-Botija from Dr. Antoni Bayés-Genís group, Hospital Germans 
Trias i Pujol, Badalona (Spain) 
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sucrose. 50 µL of the first suspension was carefully injected inside 8 mm diameter bare 
and filled scaffolds for gene and protein profile studies and inside 5 mm diameter ones 
for image analyses. The second cell suspension was injected in 5 mm bare and filled 
scaffolds for viability studies. After injection, the samples were incubated under soft 
shaking during 30 min to allow the cells to migrate slightly into the construct. Finally, 
250 µL and 150 µL of fresh medium were added in each well of the 48-wells and 96-
wells plate, respectively, allowing the peptide to gel (see Figure 1). Thus, the final cell 
density was 625 cells/µL for all samples. Samples were cultured under standard 
conditions (37 ºC and 5 % CO2) during 1 and 7 days. For cell maintenance half of the 
culture medium was changed daily. The same procedure was performed with bare 
scaffolds prefilled with PBS in place of RAD16-I, which were used as controls. 
 
Figure 1: Methodology scheme. PEA elastomeric membranes were polymerized leaving interconnected spherical 
pores. Here a section of the scaffold is observed. The scaffolds were filled with RAD16-I (composites) or PBS (bare 
PEA) using vacuum. Finally, subATDPCs were injected inside the scaffolds. Scaffold size and cell number were 
dependent on the analysis but cell density was maintained (625 cells/µL). 
2.4  Cell viability MTT assay 
Cell viability was assessed in 5 mm diameter scaffolds by the MTT assay according to 
the manufacturer’s instructions. It is based in the reduction of the yellow tetrazolium 
salt MTT to formazan crystals giving purple color. This reaction only takes place when 
cellular reductase enzymes are active and, therefore, conversion is often used as a 
measure of viable cells, referred to his metabolic activity. Briefly, after 1 and 10 days of 
culture, the media were aspirated, and MTT reagent (Sigma) was added at a final 
concentration of 0.5 mg/mL in culture medium. The samples were incubated for 3 hours 
at 37 ºC in the dark. After this time, formazan crystals were dissolved by soaking the 
samples in 300 μl of dimethylsulfoxide (DMSO) about 10 min. The absorbance was 
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read at 550 nm with a BIOTECH ELX 800 spectrophotometer. Scaffolds without cells 
were used as negative controls. All samples were analyzed in triplicate.  
2.5  Immunocytochemistry  
The cell morphology and distribution were observed by confocal microscopy in bare 
scaffolds and composites (bioimplants). After 7 days of culture, the samples were fixed 
for 20 min with paraformaldehyde (Panreac) at 4 % in phosphate buffer (PB 0.1 M) and 
the expression of α-actinin (ACTN1) and F-actin was examined.  
Briefly, samples were washed with PBS and permeabilized during 60 min with PBS- 
BSA 1 % (PBSA). Next, samples were incubated overnight with monoclonal anti-α-
actinin (Sarcomeric) Clone EA-53 (1:100; Sigma) diluted in PBSA, and exposed to 
secondary antibody (goat anti-mouse 488, 1:200, DakoCytomation) during 1 h at room 
temperature. Then, samples were stained with a selective marker for F-actin (Alexa 
Fluor Phalloidin 647, 1:200; Invitrogen) in PBSA for 2 h at room temperature. Nuclei 
were counter-stained with 4',6-diamidino-2-phenylindole (DAPI, 1:5000) for 5 min. 
Finally, samples were cryoprotected by immersion in 0.1 M PB containing 30 % 
sucrose during 1 day and included in OCT. Sections of 100 µm were obtained using a 
cryostat (Leica, CM 1900) and examined under a confocal microscopy (Olympus 
FV1000).  
2.6  Scanning electron microscopy (SEM) 
Cultured samples were treated using standard procedures in order to examine cell 
morphology and their layout on the surface of the scaffolds by scanning electron 
microscopy (SEM). Samples were fixed with 2.5 % glutaraldehyde in PB 0.1 M for 60 
min at 37 ºC. Then, they were treated with 1 % osmium tetraoxide for 2 h, followed by 
dehydration using increasing concentrations of ethanol every 10 min (30º, 50º, 70º, 96º, 
100º). Finally, samples were air dried and sputtered with gold before observation in a 
Hitachi (S-4800) microscope at 15 kV. Bare and gel-filled scaffolds were examined for 
the sake of comparison. 
2.7 Study of gene expression by RT-PCR 
Reverse transcription polymerase chain reaction (RT-PCR) was performed to analyze 
gene expression in cultured films, bare scaffolds and bioimplants. The samples were 
lysed, and RNA was extracted with PeqGold Total RNA kit (Peqlab), followed by 
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cDNA synthesis with a reverse transcriptase enzyme using Quantitect Reverse 
Transcription Kit (Qiagen) according to the manufacturer protocol. PCR reaction was 
carried out using 30 ng of cDNA in a 25 μL final volume containing 1X ThermoPol 
Reaction Buffer (stock 10X), 0.05 units of TAQ DNA polymerase (Sigma), 200 μM of 
dNTPs (Sigma) and 0.3 μM primers (Sigma). The PCR took place under the following 
conditions: 3 min at 95 ºC (activation) followed by 35 cycles of 30 s at 95ºC, 20 s of 
annealing (Tm dependent on primer pair, see Table 1) and 30 s at 72ºC. The final 
extension step was performed at 72 ºC during 15 min. PCR products were size-
fractionated by 2 % agarose gel electrophoresis. 
2.8 Study of gene expression by Real Time RT-PCR  
Real Time RT-PCR (qRT-PCR) reactions were performed with LightCycler® 480 Real-
Time PCR System (Roche), using the iQ™ SYBR® Green Supermix (Bio-Rad) as a 
fluorescent reporter. SYBR® Green binds to double-stranded DNA and upon excitation 
emits fluorescence. Real-time RT-PCR was run with the following parameters: 1 cycle 
of 10 minutes at 95 
o
C in order to activate the hot-start iTaq™ DNA polymerase, 50 
cycles consisting in 15 seconds at 94 
o
C for denaturation of the double stranded cDNA, 
15 seconds for primer annealing (Tm dependent on primer pair, see Table 1), and 15 
seconds at 72 
o
C for extension. Finally melting curve analyses were performed to test 
the specificity of PCR products, together with agarose electrophoresis. Relative gene 
fold variations were all determined by the comparative CT method (2
-ΔΔCt
) and 
expression of the target genes was normalized to the housekeeping gene (ribosomal 
protein 22L, RPL22).  




2.9 Western blotting analysis 
8 mm diameter bioimplants were cut in small pieces and lysed with the help of a pestle 
to crush them using RIPA buffer containing proteinase inhibitor cocktail (Roche). The 
protein content of the supernatant was determined using a Micro BCA
TM 
Protein assay 
kit (Pierce-Thermo Scientific). Equal amounts of total protein (5 µg) were separated by 
electrophoresis on 10 % SDS-PAGE gels at 150 V during 1 h 30 min. Subsequently, the 
proteins were transferred using wet transference on PVDF membranes (Invitrogen) 
during 2 h at 40 V. The PVDF membranes were blocked with 5 % milk buffer during 2 
h at room temperature. The membranes were incubated with rabbit polyclonal anti-
GATA4 (sc-9053, Santa Cruz), rabbit polyclonal anti-GJA1 (sc-9059, Santa Cruz) and 
rabbit polyclonal anti-TBX5 (sc-48782, Santa Cruz) at room temperature during 1 h. 
After 3 washes with PBST (Phosphate Buffered Saline (Gibco; 18912-014) 
complemented with Tween-20 (Sigma; P-1379)) and an overnight PBST wash, the blots 
were incubated with peroxidase-conjugated to rabbit IgG goat polyclonal secondary 
antibody (ab97051, Abcam). The protein bands were detected after incubation with 
SuperSignal
®
 West Pico Chemiluminescent Substrate (34080, Thermo Scientific) using 
ImageQuant LAS 4000 mini equipment. Goat polyclonal anti-Actin antibody (sc-1615, 
Santa Cruz) was used to normalize with peroxidase-conjugated to goat IgG rabbit 
polyclonal as secondary antibody (ab97100, Abcam).   
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2.10 Statistical analysis 
GraphPad was used for all statistical analyses. The results are given as mean ± standard 
deviation as obtained of three independent experiments per group. Comparison of 
means was performed by two-way analysis of variance with Bonferroni’s posttest. 
Comparison of assays was made by correlation and linear regression analysis. 




3.1  Characterization of bare PEA scaffolds and composites 
The RAD16-I peptide solution was successfully loaded and gelled inside the PEA 
scaffolds’ pores using the protocol described previously by Vallés-Lluch et al. [34]. The 
obtaining of the desired composites was confirmed by SEM imaging (Figure 2). As it 
can be observed, the loaded self-assembling peptide solution gives rise to a nanofiber 
network distributed all along the PEA scaffold pore. This nanofiber structure does not 
appear when scaffolds are loaded with PBS instead (image not shown). 
 
Figure 2: Assessment of composite formation. SEM images of surface (a) and sections of bare (b) and RAD16-I 
filled PEA scaffolds (c). (d) Detail of RAD16-I nanofibers. Scale bare: 1 mm (a), 20 µm (b), 10 µm (c), and 5 µm (d). 
3.2 Viability, growth and distribution of subATDPCs inside bare scaffolds or composites 
SubATDPCs’ viability inside bare and gel-filled scaffolds was monitored after 1 and 10 
days of culture by MTT colorimetric assay (Figure 3). The MTT test revealed that there 
were no significant differences in terms of viability between cells growing in bare PEA 
membranes and those cultured in the composites containing the self-assembling peptide 
RAD16-I (Figure 3a). In both structures, cell growth was observed at the same extent. 
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Interestingly, it was noticed that after 10 days of culture a significant fraction of the 
cells did not remain in the inner pores of the PEA scaffolds migrating outwards to end 
adhered on the surface of the well (data not shown). This effect was found to be 
enhanced in the case of the composite with 53% of the total cells detected on the surface 
of the well (Figure 3b). Instead, 36% of seeded cells in bare PEA membranes were 
detected outside the scaffold. It can also be appreciated in Figure 2c that the purplish 
intensity from formazan crystals is stronger in bare scaffolds than in the composites. 
These results indicate that cell mobilization is enhanced in the case of composites, 
which suggest it is a good platform to assure cell delivery to the affected tissue.  
 
Figure 3: MTT viability assay of subATDPCs growing inside bare PEA scaffolds and composites (PEA 
scaffold + RAD16-I self-assembling peptide). (a) SubATDPCs proliferation from day 1 to day 10 within both 
structures. (b) Cell distributions inside the structures and on the culture plate at day 10 of culture. (c) Coloration of 
both structures owing to the formation of formazan crystals. (** P<0.01 and *** p<0.001) 
3.3  subATDPCs layout in bare scaffolds or composites  
For the examination of cell distribution in scaffolds, general cell staining with 
Phalloidin (acting filaments) and DAPI (nuclei) was assessed after 7 days of culture. 
Composites show much more uniform cell distribution than in bare PEA scaffolds 
(Figure 4). SubATDPCs display a more elongated morphology around the pores of bare 
scaffolds, covering the PEA trabeculae as compared to composites where cells show a 




Figure 4: Surface CLSM images of cultured composites and bare PEA scaffolds. Phalloidin (red) staining of 
subATDPCs growing in the pores of composites (a and b) and bare PEA scaffolds (c and d). DAPI staining for nuclei 
(blue). Scale bar: 100 µm (a and c) and 50 µm (b and d).  
Samples were also labeled with ACTN1 marker, which recognizes α-skeletal muscle 
actinin and α-cardiac muscle actinin (Figure 5). ACTN1 seem to be expressed more 
homogeneously across the composite than bare PEA scaffolds (Figure 5). 
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Figure 5: Surface CLSM images of cultured composites and bare PEA scaffolds. ACTN1 (green) staining of 
subATDPCs growing in pores of composites (a and b) and bare PEA scaffolds (c and d). DAPI staining for nuclei 
(blue). Scale bar: 100 µm (a and c) and 50 µm (b and d).  
In both cases, a significant fraction of cells resided on the top of the scaffolds. SEM 
imaging proved that subATDPCs were able to cover bare PEA and composites’ surfaces 
(Figure 6). Significantly, subATDPCs growing in composites were uniformly 
distributed covering the surface after 7 days of culture entirely, whereas, on bare PEA 
scaffolds, a heterogeneous layout was observed. Moreover, subATDPCs cultured on 
composites’ surfaces were organized in a well-ordered pattern, which would facilitate 
cell-cell contact (Figure 6b). In contrast, subATDPCs growing on bare PEA scaffolds 
exhibited a disorganized distribution adhered to PEA trabeculae and maintaining pores 
empty (Figure 6e). 
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Figure 6: SEM images of the surface of cultured bare PEA scaffolds and composites. Overview of composite (a) 
and bare PEA (d) and close up of cultured surfaces of composites (b and c) and bare PEA (e and f). Scale bar 
represents 1 mm (a and d), 100 µm (b and e), 10 µm (c) and 5 µm (f). 
3.4  Protein and gene profile of cells cultured in bare scaffolds and composites 
With the aim of characterizing subATDPCs growing in the scaffolds protein and gene 
expression of early and definitive cardiac markers were analyzed, using cells growing 
on two-dimensional (2D) PEA surfaces as controls.  
Progenitor cells identity during early cardiogenesis is regulated by spatially and 
temporally well-organized pathways and mechanisms. In the course of differentiation, 
there is a progressive restriction of undifferentiated progenitors to the different lineages 
[47]. Although the mechanisms are not well understood, various transcription factors 
that may regulate cardiac commitment and differentiation were isolated in a definite 
stage of progenitor cell differentiation [47,48]. Here, the expression of early cardiac 
markers such as GATA4 (GATA binding protein 4), TBX5 (T-box transcription factor 
5), NKX2.5 (NK2 homeobox 5), and MEF2C (Myocyte Enhancer Factor 2C); as well as 
some definitive cardiac markers such as ACTN1 (α-actinin), cTnT (Troponin T2, 
Tropomyosin-binding subunit in troponin complex), GJA1 (Gap Junction protein, 
alpha-1), and MHC (myosin, heavy chain) were examined.  
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Figure 7: Protein and gene profile of cells cultured in bare PEA scaffolds and composites. a) Western blotting. 
Protein expression of cells cultured on 2D PEA compared to cells cultured in bare PEA scaffolds (RAD16-I -) and 
composites (RAD16-I +). C+ stands for the positive control for each protein. b) RT-PCR. Gene expression of cells 
cultured on 2D PEA compared to cells cultured in bare PEA scaffolds and composites. C- stands for the negative 
control used. c) qRT-PCR. The expression of TBX5 and GJA1 were assessed by Real Time RT-PCR experiments, 
establishing the base line through conventional monolayer cultures on PEA surfaces. No significant differences were 
observed between bare PEA and composites (p>0.05). 
The expression of TBX5 early cardiac marker was found both at protein and gene level 
(Figure 7a and c, respectively). Real time RT-PCR showed no significant (p>0.05) 
difference between subATDPCs cultured in bare PEA or in composites. This early 
cardiac marker is critical in heart development, and has been shown to interact with 
NKX2.5, GATA4 and MEF2C to synergistically activate target genes expression in 
cardiomyocytes [49]. A light band of MEF2C was detected by RT-PCR (Figure 7b). 
This gene plays a key role in myogenesis [50] and has long been associated with the 
regulation of myocardial-expressed genes [51]. The expression of GATA4 and NKX2.5, 
also early cardiac markers, was not detected, which was not surprising at this early time 
point considering that at least 1 to 4 weeks have been reported to be needed for 
implanted mesenchymal stem cells to reach differentiation into cardiomyocytes within 
heart [52]. In addition, definitive cardiac markers were evaluated. GJA1, which is the 
major gap junction protein in the heart and therefore has a crucial role in the 
synchronized contraction, was analyzed at protein and gene level (Figure 7a and c). No 
significant (p>0.05) increase in gene expression (respect to 2D cultures) was detected 
by qRT-PCR (Figure 7c). Additionally, at protein level, GJA1 was not detected in any 
tested condition (Figure 7a). Moreover, MHC, ACTN1, and cTnT, at gene level were 
studied. MHC gene expression was not detected, but ACTN1 and cTnT were identified 
(Figure 7b). Finally, ACTN1 expression was detected at gene and protein levels and 
cTnT at gene level in all conditions (Figure 7B and Figure 5).  
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3. DISCUSSION 
An efficient regenerative therapy for heart function recovery after myocardial infarction 
(MI) has not been yet outlined. The obstacle resides in the vast complexity of the heart 
muscle, where different factors at macroscopic and microscopic level such as heart 
contraction and cell connectivity, among others, must be taken into account to repair the 
damaged tissue. Although cell therapy appeared as an interesting approach, the 
conditions that remain after MI are not suitable for cell survival and proliferation. For 
this reason, the design and fabrication of biomaterials to be used as vehicles or even to 
give specific signaling to the cells are of great interest. These materials must be easy 
handling and cell-friendly, reproduce heart extracellular matrix, have sufficient 
mechanical stability and high porosity to lodge a high cell density, and do not produce 
an inflammatory response in vivo. Numerous polymers (natural and synthetic) have 
been widely investigated for cardiac tissue engineering, shaped in a variety of 
architectures [53–55]. These structures act as physical support for the seeded cells, 
allowing the exchange of oxygen and nutrients and removal of cellular secretions, to 
facilitate cell adhesion, survival, proliferation and differentiation [4]. On the other end, 
nanofibers in the form of self-assembling peptides emerged as a good system to better 
recreate a 3D environment [56]. Three-dimensional structures are essential for an 
appropriate spatial organization of cell surface receptors involved in cell–cell and cell-
ECM interactions [57]. Here, a combination of PEA elastomeric membrane with 
RAD16-I self-assembling peptide is proposed and analyzed. PEA elastomeric 
membrane fulfills many of the essential characteristics prescribed for necrotic 
myocardium repair, but it fails to emulate the cardiac tissue at the nano-scale. The 
peptide gel network provided by RAD16-I resembles ECM environment and has been 
shown to increase growth and cellular proliferation of different cell types. However, the 
RAD16-I poor mechanical properties are an important drawback for its implantation in 
the continuous beating heart [58]. Therefore, the combination of this soft material with 
synthetic polymeric materials with improved elasticity and tensile strength arise as an 
interesting approach. Both materials would contribute to the implant success at different 
levels: the polymeric elastomeric membrane would be responsible for providing an 
adequate physical support, whereas the natural gel would confer an in vivo-like 
environment to the cells. 
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In this study, subATDPCs viability, growth, mobilization and progenitor phenotype 
maintenance in PEA elastomeric membrane filled with peptide gel (composites) was 
assessed in vitro. The bioactive patch developed presents a good advantage as a cell 
vehicle for cell therapies. It has been demonstrated by MTT analysis that cells can 
proliferate within this milieu to a five-fold increase after 10 days of in vitro culture, and 
similarly in bare scaffolds (p<0.001). The gel works as cell diffusion medium, 
facilitating the invasibility of the scaffold’s pores upon seeding and after 10 days both 
the polymeric surface and the inner trabeculae were covered with cells [42]. In the 
composites, subATDPCs completely covered the surface of the scaffolds and adopted 
an elongated shape, contacting one to each other. However, expression of GJA1 was not 
detected, which means that, at this time point, the cell-cell connectivity for low 
molecular weight molecules diffusivity was not assembled [59]. In bare scaffolds, cells 
remain adhered on the PEA trabeculae and arrange forming circumferences, rather than 
occupying the ‘empty’ pores. The well-known outstanding cell adhesion and biological 
performance of PEA hinders though cell migration to the surface of the patch [34,42]. 
The main advantaged of the composite resides in the capacity of promoting cell 
mobilization outwards, which could facilitate cell grafting at the affected site.  
subATDPCs (MSC-like) were used in this work due to their cardiogenic potential 
lineage. It was the primary aim to ensure that these cells in the proposed biomaterials 
(bare PEA or the composite) did not alter their genetic profile. As described, 
subATDPCs preserved their cardiogenic potential lineage by the expression of early 
cardiac markers such as TBX5 and MEF2C or definitive markers such as ACTN1 and 
cTnT. No significant differences in gene or protein expression between the cells 
cultured in composites, bare scaffolds and controls. TBX5 early cardiac marker is 
critical in heart development, and it has been reported to regulate the activity of other 
genes by attaching to specific regions of DNA [49]. It has also been shown to interact 
with NKX2.5, GATA4 and MEF2C to synergistically activate target genes expression 
in cardiomyocytes [49]. MEF2C expression, which plays a key role in myogenesis, has 
been related with the expression of genes such as ACTN1 and MHC. In terms of 
definitive cardiac markers, ACTN1 is a marker of mature cardiomyocytes that helps to 
anchor the myofibrillar actin filaments. It is the major component of the contractile 
apparatus [60]. cTnT, a constituent of the troponin complex, which connects the 
troponin complex to tropomyosin regulating muscle contraction in response to alteration 
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in intercellular calcium concentration, was also detected. This complex controls the 
calcium mediated interaction between actin and myosin. In contrast with other 
multigene families, the skeletal and cardiac proteins of this complex are not derived 
from alternative splicing of exons from a single gene [61]. Therefore, they have, 
theoretically, the potential of being unique to the myocardium. This led us to 
hypothesize that subATDPCs would be able to differentiate towards a cardiac-like 
phenotype. Although these results are not conclusive to resolve a differentiation toward 
a cardiac phenotype, we observe that subATDPCs maintain their phenotype after 10 
days of culture in both bare PEA and the composite. Therefore, we think that this 
biomaterial is not cardioconductive but is able to preserve cell potentiality, which could 
facilitate their lineage commitment. Further analysis at longer time points and using 
different kind of induction (chemical or physical) would be important to elucidate 
possible cardiac differentiation at more definitive stages. Therefore, it was concluded 
that the PEA elastomeric scaffold, with or without RAD16-I gel in the pores, is a non-
inductive milieu where subATDPCs can survive, grow and mobilize after implantation 
at the ischemic tissue. 
4 CONCLUSIONS 
The high complexity found in heart tissue makes it impossible to find a unique material 
that fulfills all the needed requirements to regenerate infarcted tissue. In this study we 
demonstrate the benefits provided by the combination of two synthetic biomaterials 
with really different properties. This combination allows obtaining a biomaterial with 
proper mechanical properties and verified suitable microenvironment for cell culture. 
RAD16-I was introduced inside the PEA elastomeric membrane pores with the aim of 
creating a milieu that can imitate more properly the in vivo environment. Additionally, it 
was pretended to improve cell adhesion following the preparation of the bioactive 
implant and promote cell proliferation over time [34]. The final intention of the 
bioactive implant proposed is to be implanted on an ischemic heart, and it is hoped that 
it helps to maintain the seeded cells in the affected area, which would increase their 
effect. The improved cell diffusion through the peptide in the pores suggests that when 
implanted in an in vivo model of MI, the grafted cells would be able to migrate towards 
the necrotic cardiac tissue. On the contrary, whether the pre-seeded bare scaffold was 
implanted, cells would preferably remain within the pores. It is expected that after 
 20 
implantation of the developed patch, cells would be able to migrate towards the necrotic 
zone, producing some paracrine effect [62] and stimulate tissue regeneration. 
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